Allspring Global Investments Holdings, LLC Protagonist Therapeutics, Inc Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 5,975 shares of PTGX stock, worth $215,996. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,975
Previous 103,842
94.25%
Holding current value
$215,996
Previous $4.67 Million
95.07%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PTGX
# of Institutions
254Shares Held
58.9MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$214 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$208 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$199 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$153 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$120 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.77B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...